Scientific and Medical Equipment House carries a market capitalization of 878.40M, placing it among publicly traded companies globally. Its enterprise value stands at 1.07B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 878.40M |
| Enterprise Value | 1.07B |
Scientific and Medical Equipment House currently has 30.00M shares outstanding.
| Shares Outstanding | 30.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Scientific and Medical Equipment House trades at a trailing price-to-earnings ratio of 32.45. The price-to-sales ratio is 1.11, and the price-to-book ratio stands at 1.96.
| PE Ratio | 32.45 |
| PS Ratio | 1.11 |
| PB Ratio | 1.96 |
| P/TBV Ratio | 1.86 |
| P/FCF Ratio | 73.26 |
| P/OCF Ratio | 144.54 |
On an enterprise value basis, Scientific and Medical Equipment House trades at an EV/EBITDA multiple of 31.37 and an EV/FCF ratio of 42.15. The EV/Sales ratio of 1.27 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 31.37 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.27 |
| EV / EBITDA | 31.37 |
| EV / EBIT | 31.37 |
| EV / FCF | 42.15 |
Scientific and Medical Equipment House maintains a current ratio of 2.44, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 35.16, indicating elevated leverage, while an interest coverage ratio of 1.84 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.44 |
| Quick Ratio | 0.12 |
| Debt / Equity | 35.16 |
| Debt / EBITDA | 5.23 |
| Interest Coverage | 1.84 |
Scientific and Medical Equipment House posts a return on equity of 6.04 and a return on invested capital of 3.42.
| Return on Equity (ROE) | 6.04 |
| Return on Assets (ROA) | 3.15 |
| Return on Invested Capital (ROIC) | 3.42 |
| Return on Capital Employed (ROCE) | 6.90 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 8.53 |
Over the trailing twelve months, Scientific and Medical Equipment House has paid 12.68M in income taxes, reflecting an effective tax rate of 32.07.
| Income Tax | 12.68M |
| Effective Tax Rate | 32.07 |
Scientific and Medical Equipment House's stock has declined approximately -23.43096% over the past 52 weeks. The 50-day moving average sits at 30.42, while the 200-day moving average is 32.64.
| Beta (5Y) | N/A |
| 52-Week Price Change | -23.43096% |
| 50-Day Moving Average | 30.42 |
| 200-Day Moving Average | 32.64 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Scientific and Medical Equipment House generated 846.57M in revenue and converted that into 29.03M in net income, yielding earnings per share of 0.90. EBITDA reached 34.19M, while operating income came in at 34.19M.
| Revenue | 846.57M |
| Gross Profit | 113.49M |
| Operating Income | 34.19M |
| Pretax Income | 39.55M |
| Net Income | 29.03M |
| EBITDA | 34.19M |
| EBIT | 34.19M |
| Earnings Per Share (EPS) | 0.90 |
Scientific and Medical Equipment House holds 40.28M in cash and equivalents against 178.93M in total debt, resulting in a net debt position of 124.94M. Total book value stands at 480.38M, with working capital of 502.97M providing operational flexibility.
| Cash & Cash Equivalents | 40.28M |
| Total Debt | 178.93M |
| Net Debt | 124.94M |
| Equity (Book Value) | 480.38M |
| Book Value Per Share | 16.01 |
| Working Capital | 502.97M |
Scientific and Medical Equipment House produced 6.52M in operating cash flow over the past twelve months. After subtracting -6.34M in capital expenditures, free cash flow totaled 177,123.00 - equivalent to 0.01 per share.
| Operating Cash Flow | 6.52M |
| Capital Expenditures | -6.34M |
| Free Cash Flow | 177,123.00 |
| FCF Per Share | 0.01 |
Scientific and Medical Equipment House operates with a gross margin of 13.41, reflecting its pricing power and cost economics. The operating margin of 4.04 and net profit margin of 3.43 provide insight into operational efficiency.
| Gross Margin | 13.41 |
| Operating Margin | 4.04 |
| Pretax Margin | 4.67 |
| Profit Margin | 3.43 |
| EBITDA Margin | 4.04 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 1.51 |
| FCF Yield | 1.36 |
Scientific and Medical Equipment House's most recent stock split took place on September 4, 2023 with a 2:3 split ratio.
| Last Split Date | 9/4/2023 |
| Split Ratio | 2:3 |
Scientific and Medical Equipment House posts an Altman Z-Score of 3.24, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.24 |